Associated tags: Biotechnology, Envision, Patient, Health
Locations: FAIRFIELD, PHILADELPHIA, TOKYO, PA, NORTH AMERICA, CONNECTICUT, APAC, ALICE, UK
Retrieved on:
Thursday, January 18, 2024
FAIRFIELD, Conn., Jan 18, 2024 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team.
Key Points:
- FAIRFIELD, Conn., Jan 18, 2024 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team.
- "We are thrilled to welcome Carolyn, who's proven herself as a people-leading expert in the life sciences industry, to Envision as our new Chief People Officer," says Howard Miller, CEO of Envision Pharma Group.
- In this role, Carolyn completed multiple company HR integrations and created a mobility program to retain top talent.
- "I am excited to bring my talents to such an innovative and progressive company as Envision Pharma Group," adds Carolyn.
Retrieved on:
Tuesday, January 16, 2024
HORSHAM, UK, Jan 16, 2024 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) and a member of its Executive Leadership Team.
Key Points:
- HORSHAM, UK, Jan 16, 2024 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) and a member of its Executive Leadership Team.
- In her new role, Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery, patient engagement, and more to deliver smarter, faster outcomes for life sciences clients.
- "I am so pleased to welcome Alice to the Envision team and her invaluable experience as a global life sciences industry leader," shares Howard Miller, CEO of Envision Pharma Group.
- Alice joins Envision from IPG Health where she most recently served as EVP, Managing Director, Client Solutions, APAC.
Retrieved on:
Wednesday, November 15, 2023
HORSHAM, UK, Nov 15, 2023 - (ACN Newswire) - Envision Pharma Group (Envision), a leading global technology-enabled strategic solutions partner for the life sciences industry, unveils its AI Innovation Board and announces the appointment of Dr. Loubna Bouarfa as AI thought leader and Chairwoman of the newly established board.
Key Points:
- HORSHAM, UK, Nov 15, 2023 - (ACN Newswire) - Envision Pharma Group (Envision), a leading global technology-enabled strategic solutions partner for the life sciences industry, unveils its AI Innovation Board and announces the appointment of Dr. Loubna Bouarfa as AI thought leader and Chairwoman of the newly established board.
- In this new role, she will apply her deep expertise to intertwine AI with all the services that Envision offers.
- "Loubna's appointment and the establishment of the new AI Innovation Board marks a significant step toward aligning our innovation and technology efforts to drive our strategies for our internal team, business, and partners," shares Howard Miller, CEO of Envision Pharma Group.
- In addition, Dr. Bouarfa will lead the AI Innovation Board to define and develop Envision's AI strategy across all technology platforms, solidify thought leadership as pioneers in AI, and pilot new innovative AI applications.
Envision,
Science,
Data science,
Anvar,
Doctor of Philosophy,
Acquisition,
Patient,
Master of Science,
Pleasure,
Artificial intelligence,
Brunel University London,
Faculty,
AI,
Health,
Leiden University Medical Center,
Computational biology,
Leiden University,
Medical device,
Medicine PHILADELPHIA, PA, June 15, 2023 - (ACN Newswire) - OKRA.ai, an Envision Pharma Group (Envision) company, has appointed senior leader Dr. Yahya Anvar as Chief of AI Science & Insights to unleash the full potential of artificial intelligence (AI) and to further support the life sciences industry.
Key Points:
- PHILADELPHIA, PA, June 15, 2023 - (ACN Newswire) - OKRA.ai, an Envision Pharma Group (Envision) company, has appointed senior leader Dr. Yahya Anvar as Chief of AI Science & Insights to unleash the full potential of artificial intelligence (AI) and to further support the life sciences industry.
- "I am excited about continuing the innovative collaboration between Envision and OKRA.ai along with Yahya as a senior leader as it further solidifies our Envision commitment to the expansion of OKRA.ai and leadership in the AI and technical space," shares Meg Heim, CEO of Envision Pharma Group.
- His role has now expanded to cover AI insights and scientific expertise across the entire Envision organization following our recent acquisition.
- I look forward to working with him in driving AI innovation and propelling Envision to new heights."
Envision,
University,
Therapy,
Health,
TPG Inc.,
Chief commercial officer,
Technology Credit Union,
Business,
MBA,
Kaiser Permanente,
Silicon,
Artificial intelligence,
Johnson & Johnson,
Stanford Graduate School of Business,
Software,
Pharmaceutical industry,
Management,
Oracle,
Genentech,
San Francisco Bay Area PHILADELPHIA, PA, May 10, 2023 - (ACN Newswire) - Envision Pharma Group (Envision) today announced the appointment of Dr. Deepti Sodhi Jaggi to the Envision Board of Directors.
Key Points:
- PHILADELPHIA, PA, May 10, 2023 - (ACN Newswire) - Envision Pharma Group (Envision) today announced the appointment of Dr. Deepti Sodhi Jaggi to the Envision Board of Directors.
- "We are pleased to welcome Deepti to the Envision Board of Directors," shares Meg Heim, CEO of Envision Pharma Group.
- Dr. Jaggi's career includes over 20 years of experience in driving innovation at the intersection of life sciences, healthcare, and technology.
- "I am thrilled to join the Envision Board at such an exciting time for our industry.
Acceleration,
Envision,
BCPS,
Doctor of Pharmacy,
Chicago Innovation Awards,
CV,
Public affairs,
Heart failure,
University,
Diabetes,
Bristol Myers Squibb,
Sri Satya Sai University of Technology & Medical Sciences,
Pharmacy,
Science,
Rutgers University,
American College of Clinical Pharmacy,
Publication,
Patient,
Access,
Commercial,
BMS,
Nursing care plan,
ASHP,
American College,
CMPP,
Pharmaceutical industry,
Nursing,
Northeastern University PHILADELPHIA, PA, May 4, 2023 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Dr. Jennifer Costello, PharmD, BCPS, CMPP, to the role of Chief Medical Officer.
Key Points:
- PHILADELPHIA, PA, May 4, 2023 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Dr. Jennifer Costello, PharmD, BCPS, CMPP, to the role of Chief Medical Officer.
- Meg Heim, CEO of Envision Pharma Group, adds, "I am so excited to welcome Jennifer to the Envision team as Chief Medical Officer.
- Jennifer is an accomplished pharmaceutical and healthcare leader with over 20 years of experience across the healthcare sector.
- Prior to joining Envision, Jennifer held multiple leadership roles in global medical affairs and publications, US HEOR publications, and global scientific content.
GSK,
GSK plc,
Senior,
Diabetes,
Virology,
Policy,
HTA,
Bristol Myers Squibb,
Creativity,
Sanofi,
Environment,
Management,
Envision PHILADELPHIA, PA, May 2, 2023 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Mike Glover to Senior Vice President, Payer and HTA Solutions.
Key Points:
- PHILADELPHIA, PA, May 2, 2023 - (ACN Newswire) - Envision Pharma Group (Envision) has appointed Mike Glover to Senior Vice President, Payer and HTA Solutions.
- Mike's key focus areas will be transformations in patient access, global pricing strategies, real-world evidence, and improving patient outcomes.
- Meg Heim, CEO of Envision Pharma Group, shares, "I am excited to welcome Mike to the team at Envision as Senior Vice President, Payer and HTA solutions.
- Prior to joining Envision, Mike served as Vice President, Head of Global Access and Pricing Strategy for GlaxoSmithKline.
